Bioextrax (Sweden) Performance

BIOEX Stock   2.34  0.46  16.43%   
The firm shows a Beta (market volatility) of -0.86, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Bioextrax are expected to decrease slowly. On the other hand, during market turmoil, Bioextrax is expected to outperform it slightly. At this point, Bioextrax AB has a negative expected return of -0.0784%. Please make sure to confirm Bioextrax's semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if Bioextrax AB performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Bioextrax AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bioextrax is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
  

Bioextrax Relative Risk vs. Return Landscape

If you would invest  328.00  in Bioextrax AB on October 4, 2025 and sell it today you would lose (48.00) from holding Bioextrax AB or give up 14.63% of portfolio value over 90 days. Bioextrax AB is generating negative expected returns and assumes 6.258% volatility on return distribution over the 90 days horizon. Simply put, 56% of stocks are less volatile than Bioextrax, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Bioextrax is expected to under-perform the market. In addition to that, the company is 8.65 times more volatile than its market benchmark. It trades about -0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Bioextrax Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioextrax's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bioextrax AB, and traders can use it to determine the average amount a Bioextrax's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0125

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBIOEX

Estimated Market Risk

 6.26
  actual daily
56
56% of assets are less volatile

Expected Return

 -0.08
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Bioextrax is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioextrax by adding Bioextrax to a well-diversified portfolio.

Things to note about Bioextrax AB performance evaluation

Checking the ongoing alerts about Bioextrax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioextrax AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bioextrax AB generated a negative expected return over the last 90 days
Bioextrax AB has high historical volatility and very poor performance
Evaluating Bioextrax's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bioextrax's stock performance include:
  • Analyzing Bioextrax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioextrax's stock is overvalued or undervalued compared to its peers.
  • Examining Bioextrax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bioextrax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioextrax's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bioextrax's stock. These opinions can provide insight into Bioextrax's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bioextrax's stock performance is not an exact science, and many factors can impact Bioextrax's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Bioextrax Stock Analysis

When running Bioextrax's price analysis, check to measure Bioextrax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioextrax is operating at the current time. Most of Bioextrax's value examination focuses on studying past and present price action to predict the probability of Bioextrax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioextrax's price. Additionally, you may evaluate how the addition of Bioextrax to your portfolios can decrease your overall portfolio volatility.